Vasculitis Trial, Recruiting (NCT06993636)

Vasculitis Trial, Recruiting NCT06993636 Sponsor: Children's Hospital of Fudan University Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT06993636 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children aged 2 years old up to (but not including) 18 years old
Children who have developed large balloon-like bulges (called giant aneurysms) in the blood vessels of the heart following Kawasaki disease, confirmed by a specific heart ultrasound test showing the bulge meets certain size measurements
Children for whom doctors have recommended a combination of blood-thinning medications to prevent dangerous blood clots, planned for at least the next 6 months

Who may not be able to join:

Children who are currently bleeding or who have a condition that puts them at high risk of bleeding, making blood-thinning medication unsafe for them
Children who have a known allergy or other medical reason why either of the medications being studied in this trial would not be suitable for them
Children who are already taking part in another clinical trial for a different medication at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fang Liu, MD, Children's Hospital of Fudan University

Phone: 18017590880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06993636

Sponsor: Children's Hospital of Fudan University

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 18017590880

More information: https://clinicaltrials.gov/study/NCT06993636

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children aged 2 years old up to (but not including) 18 years old
Children who have developed large balloon-like bulges (called giant aneurysms) in the blood vessels of the heart following Kawasaki disease, confirmed by a specific heart ultrasound test showing the bulge meets certain size measurements
Children for whom doctors have recommended a combination of blood-thinning medications to prevent dangerous blood clots, planned for at least the next 6 months

Who may not be able to join:

Children who are currently bleeding or who have a condition that puts them at high risk of bleeding, making blood-thinning medication unsafe for them
Children who have a known allergy or other medical reason why either of the medications being studied in this trial would not be suitable for them
Children who are already taking part in another clinical trial for a different medication at the same time

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Children's Hospital of Fudan University

Registry

ClinicalTrials.gov

Start date

1 January 2023

Est. completion

31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rivaroxaban plasma concentration; Rivaroxaban-calibrated anti-activated Factor X (FXa) activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov